Angiotensin II receptor type 1 mRNA is unregulated in atria of patients with end stage heart failure

被引:13
|
作者
Kaprielian, RR [1 ]
Dupont, E [1 ]
Hafizi, S [1 ]
PooleWilson, PA [1 ]
Khaghani, A [1 ]
Yacoub, MH [1 ]
Sever, NJ [1 ]
机构
[1] HAREFIELD HOSP, HEART SCI CTR, HAREFIELD UB9 6BP, MIDDX, ENGLAND
关键词
heart failure; angiotensin II receptor; myocardium;
D O I
10.1006/jmcc.1997.0458
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There is increasing evidence that pathological changes in the myocardium during chronic heart failure (CHF) are partly regulated through the activation of the renin-angiotensin system (RAS), an effect mediated by the angiotensin II type 1 receptor (AT(1)R), We examined the expression of cardiac AT(1)R mRNA in normal (atria, n=7: ventricle, n=3) and end-stage CHF human hearts (atria, n=8: ventricle, n=14). Tissue was snap-frozen immediately after explantation during orthotopic cardiac transplantation; control specimens were obtained from healthy donor hearts rejected for technical reasons. Northern blots of purified total mRNA from each tissue were hybridized with a random primed radiolabeled probe for the coding sequence of AT(1)R. Stringent conditions were used for both hybridization (5X SSC, 65 degrees C) and washing (0.5X SSC, 0.1% SDS, 65 degrees C) of the membrane, Left and right atrial tissue showed low levels of AT(1)R mRNA expression in the controls, with statistically significant upregulation of expression in tissue from pathological hearts; CHF atria 1.28+/-0.86 optical density (OD) units, control atria 0.56+/-0.31 OD units, P=0.05 (mean+/-S.D.). There were undetectable levels in ventricles from either control (2/2) or dilated hearts (7/7), The results were independent of the etiology of the heart failure and suggest that increased levels of atrial AT(1)R mRNA may occur in response to elevated atrial pressures in heart failure. (C) 1997 Academic Press Limited.
引用
收藏
页码:2299 / 2304
页数:6
相关论文
共 50 条
  • [11] Angiotensin II receptor antagonists, elite drugs (or not) for patients with heart failure or hypertension?
    Beevers, DG
    Lip, GYH
    JOURNAL OF HUMAN HYPERTENSION, 1997, 11 (06) : 329 - 330
  • [12] Angiotensin II type 2 receptor agonist treatment of doxorubicin induced heart failure
    Ermis, Necip
    Ulutas, Zeynep
    Ozhan, Onural
    Yildiz, Azibe
    Vardi, Nigar
    Colak, Cemil
    Parlakpinar, Hakan
    BIOTECHNIC & HISTOCHEMISTRY, 2023, 98 (05) : 326 - 335
  • [13] Effects of angiotensin II type 1 receptor antagonist, losartan, on ventilatory response to exercise and neurohormonal profiles in patients with chronic heart failure
    Kinugawa, T
    Kato, M
    Ogino, K
    Osaki, S
    Igawa, O
    Hisatome, I
    Shigemasa, C
    JAPANESE JOURNAL OF PHYSIOLOGY, 2004, 54 (01) : 15 - 21
  • [14] Beneficial effects on skeletal muscle of the angiotensin II type 1 receptor blocker irbesartan in experimental heart failure
    Dalla Libera, L
    Ravara, B
    Angelini, A
    Rossini, K
    Sandri, M
    Thiene, G
    Ambrosio, GB
    Vescovo, G
    CIRCULATION, 2001, 103 (17) : 2195 - 2200
  • [15] Impact of angiotensionogen and angiotensin II receptor type 1 gene polymorphisms on the development and course of chronic heart failure
    Teplyakov, A. T.
    Shilov, S. N.
    Berezikova, E. N.
    Efremov, A. V.
    Safronov, I. D.
    Pustovetova, M. G.
    Mayanskaya, S. D.
    Torim, Yu. Yu.
    Karpov, R. S.
    TERAPEVTICHESKII ARKHIV, 2013, 85 (01) : 14 - 19
  • [16] Angiotensin-II type 1 receptor gene polymorphism and long-term survival in patients with idiopathic congestive heart failure
    Andersson, B
    Blange, I
    Sylvén, C
    EUROPEAN JOURNAL OF HEART FAILURE, 1999, 1 (04) : 363 - 369
  • [17] The role of angiotensin II receptor blockers in the management of heart failure
    McMurray, JJV
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2005, 7 (0J) : J10 - J14
  • [18] Angiotensin II type 1a receptor signals are involved in the progression of heart failure in MLP-Deficient mice
    Yamamoto, Rie
    Akazawa, Hiroshi
    Ito, Kaoru
    Toko, Haruhiro
    Sano, Masanori
    Yasuda, Noritaka
    Qin, Yingjie
    Kudo, Yoko
    Sugaya, Takeshi
    Chien, Kenneth R.
    Komuro, Issei
    CIRCULATION JOURNAL, 2007, 71 (12) : 1958 - 1964
  • [19] Combining angiotensin II receptor 1 antagonism and neprilysin inhibition for the treatment of heart failure
    Katsanos, Spyridon
    Bistola, Vasiliki
    Parissis, John T.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (04) : 513 - 523
  • [20] Angiotensin Receptor-Neprilysin Inhibitor Therapy Reverses Pulmonary Hypertension in End-Stage Heart Failure Patients Awaiting Transplantation
    Zern, Emily K.
    Cheng, Susan
    Wolfson, Aaron M.
    Hamilton, Michele A.
    Zile, Michael R.
    Solomon, Scott D.
    Kittleson, Michelle M.
    CIRCULATION-HEART FAILURE, 2020, 13 (02) : E006696